Última actualización 6 de julio de 2026
Key finding
Reduction in fasting blood glucose levels in the cinnamon group was found -35.50% (95% CI, -173 to 58.4).
This study evaluated the effects of Cinnamomum zeylanicum on glycemic control in individuals with type 2 diabetes, finding significant reductions in fasting plasma glucose levels.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the effects of Cinnamomum zeylanicum on glycemic control in individuals with type 2 diabetes, finding significant reductions in fasting plasma glucose levels.
Effective management of blood sugar levels is crucial for individuals with type 2 diabetes to prevent complications. The significant reduction in fasting plasma glucose levels observed with Cinnamomum zeylanicum indicates its potential as a complementary treatment option, which could improve patient outcomes and enhance glycemic control strategies.
The study's sample size may limit the generalizability of the findings. The duration of the intervention was not specified, which could affect long-term outcomes. Potential confounding factors were not fully addressed.
Published in
Publication details and source links for this paper.
Alexander M, John RA, Anindita M, et al. Effects of Cinnamomum zeylanicum on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial. Cureus. 2023;15(2):e35023. doi:10.7759/cureus.35023
Cinnamomum zeylanicum reduced fasting plasma glucose by 35.5% (p=0.001).
Glycosylated hemoglobin (HbA1c) decreased by 0.85% in the cinnamon group (p=0.039).
Significant inhibition of PTP1B expression was observed (p=0.039).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Cinnamomum zeylanicum and Fasting Plasma Glucose (FPG), HbA1c, PTP1B expression.
This study contributes evidence to
Primary intervention
Cinnamomum zeylanicum
Primary outcomes
Evidence topics
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
2
Related topics
3
Evidence pairs
555
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Tema de evidencia
matched_outcome
Evidencia relacionada
Tema de evidencia
Guardar evidencia
Core evidence
The primary outcomes reported in this study.
Cinnamomum zeylanicum → Fasting Plasma Glucose (FPG)
Cinnamomum zeylanicum → Fasting Plasma Glucose (FPG)
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Cinnamomum zeylanicum and Fasting Glucose, Cinnamomum zeylanicum and HbA1c.
This study contributes to the evidence on the following intervention-outcome relationships.
Supplements
Supplements
Curated evidence collections and hubs this study is part of.
All studies on Cinnamomum zeylanicum
Contributes to Cinnamomum zeylanicum evidence base.
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Cinnamomum zeylanicum appears to improve Fasting Plasma Glucose (FPG).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Cinnamomum zeylanicum appears to improve HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Cinnamomum zeylanicum appears to improve PTP1B expression.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
PTP1B expression
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Follow the topics this study contributes to.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Centrada en la evidencia, no en la publicidad.
Tus datos siempre están protegidos.
Se agregan nuevos estudios todos los días.
